|
The Rimonabant Report - News About Diet Drugs |
| |
Welcome to the Rimonabant Report, where you can obtain the latest news about the launch of the Sanofi-Aventis anti-obesity drug Acomplia® in countries around the world -- as well as news of efforts by several Indian pharmaceutical companies to market generic versions of rimonabant.
Whatever the name, rimonabant has been hailed by some doctors on the basis of study results as potentially a major breakthrough in treating obesity. Some 200,000 Europeans are now taking Acomplia. However, Sanofi's efforts to market rimonabant in the U.S. as Zimulti have been indefinitely delayed by concerns over depression and other side-effects.
The Rimonabant Report, updated daily, will provide the latest news and reviews related to development and sale of rimonabant. |
| |
Rimonabant News for October 2008 --News About Diet Drugs |
| |
 European Agency Calls for Withdrawal of Diet Pill Rimonabant From Market
Merck Pulls Plug on Development of CB1 Obesity Drug, Taranabant
|
| |
Rimonabant News for August 2008 --News About Diet Drugs |
| |
Study: Rimonabant May Increase Risk of Colorectal Cancer
Targeting Peripheral CB1 Receptors May Avoid Rimonabant Side-Effects |
| |
Rimonabant News for July 2008 --News About Diet Drugs |
| |
Global Sales of Diet Drug Acomplia Edge Up to $50 Million in 2nd Quarter
|
| |
Rimonabant News for June 2008 --News About Diet Drugs |
| |
Acomplia Significantly Improves Glucose Control of Diabetic Patients
|
| |
Rimonabant News for May 2008 --News About Diet Drugs |
| |
CT Scans Confirm Rimonabant Reduces Dangerous Abdominal Obesity
|
| |
Rimonabant News for April 2008 --News About Diet Drugs |
| |
Rimonabant Disappoints in Heart Study; Side Effects Also an Issue
|
| |
Rimonabant News for March 2008 --News About Diet Drugs |
| |
Diet Pill Taranabant Effective at Much Lower Dose Than Rimonabant
Diet Drug Rimonabant (Acomplia) Gets Boost From British Health Panel
Rimonabant May Cause Depression by Blocking TRPV1 Receptor in Brain
Report: Taranabant Side-Effect Profile May Be Similar to Rimonabant
Diet Drug Rimonabant May Help Block Development of Alcoholic Fatty Liver
Sanofi's Acomplia Again Turned Down for Insurance Coverage in Germany
Pfizer Lagging Behind Merck in Developing Competitor to Rimonabant |
| |
Rimonabant News for February 2008 --News About Diet Drugs |
| |
Are Lagging Acomplia Sales Being Hurt by Generic Rimonabant?
|
| |
Rimonabant News for January 2008 --News About Diet Drugs |
| |
Will Diet Drug Taranabant Be This Year's Rimonabant?
|
| |
Rimonabant News for December 2007--News About Diet Drugs |
| |
Merck on Track to File for FDA Approval of Diet Drug Taranabant in 2008
UK Panel Says Inclined 'Not to Recommend' Diet Pill Rimonabant for NHS
|
| |
Rimonabant News for November 2007--News About Diet Drugs |
| |
Study Links Diet Drug Rimonabant to 'Severe Adverse Psychiatric Events'
Study: Rimonabant Weight Loss 'Modest' and Safe-Effects Are Concern
Class Action Lawsuit Filed Against Sanofi Over Acomplia (Rimonabant)
Sanofi Allowed to Inform Patients Taking Acomplia It Aids Glucose Control
Acomplia Sales Disappoint; No Major Improvement Seen Until 2009 |
| |
Rimonabant News for October 2007--News About Diet Drugs |
| |
Taranabant Yields Encouraging Results With 'Generally Mild' Side-Effects
First Official Report on Taranabant -- Rimonabant Competitor -- Due Oct. 24
|
| |
Rimonabant News for September 2007--News About Diet Drugs |
| |
Rimonabant Found to Significantly Reduce Dangerous Abdominal Fat
Sanofi Disappoints Dieters; Won't Try to Sell Acomplia in U.S. for Years
Vernalis Reports 'Striking Weight Loss' for Diet Drug Similar to Rimonabant
Taranabant, Competitor to Rimonabant, in Final Months of Clinical Trial |
| |
Rimonabant News for August 2007--News About Diet Drugs |
| |
Copies of Acomplia (Rimonabant) Being Sold Without Prescription in India
Americans Will Not Be Able to Buy Rimonabant in U.S. Anytime Soon |
| |
Rimonabant News for July 2007--News About Diet Drugs |
| |
European Regulators Decide Rimonabant Should Remain on Market
Study: Rimonabant May Reduce Obesity-Related Liver Damage
Diet Drug Rimonabant Now Seen by Sanofi as Requiring Indefinite Use |
| |
Rimonabant News for June 2007 -- News About Diet Drugs |
| |
Sanofi Pulls U.S. Application for Sale of Diet Drug Acomplia (Rimonabant)
Court: Sanofi's Diet Drug Acomplia Will Not Be Reimbursed in Germany
Indian Pharmas: No Plans to Withdraw Rimonabant From the Market
European Regulators to Review Safety Data for Sanofi's Acomplia
FDA Panel Recommends Against Sale of Sanofi's Acomplia in U.S.
Delay in U.S. Approval of Sanofi's Rimonabant Tied to Suicide, Seizures
Vexing Month for Sanofi Over Rimonabant Likely to Peak in Week Ahead
Sellers of Diet Drug Rimonabant Unfazed by Competition from Acomplia
Acomplia (Rimonabant) Diet Pill Goes on Sale in United Arab Emirates
Sanofi's Acomplia (Rimonabant) Widely Found in Mexican Pharmacies |
| |
Rimonabant News for May 2007 -- News About Diet Drugs |
| |
Added Health Claims for Diet Drug Rimonabant Questioned in Britain
Do Indian Versions of Diet Drug Rimonabant Work the Same as Acomplia
How Indian Pharmas Beat Sanofi to the Market With Diet Drug Rimonabant
Sanofi 'Examining Options' Against Sellers Offering Generic Rimonabant
2nd Generic Version of Rimonabant (Acomplia / Zimulti) Hits Market in India
Generic Version of Rimonabant (Acomplia / Zimulti) Launched in India
Raids in Europe Crack Ring Selling Counterfeit Acomplia on the Internet |
| |
Rimonabant News for April 2007 -- News About Diet Drugs |
| |
Diet Drug Acomplia (Rimonabant) Approved for Sale in Brazil
It's Official. Diet Drug Acomplia (Rimonabant) to Use Name Zimulti in U.S.
Diet Drug Acomplia (Rimonabant) Approved for Sale in Switzerland
Competitor for Diet Drug Rimonabant Now Has a Name: Taranabant |
| |
Rimonabant News for March 2007--News About Diet Drugs |
| |
Diet Drug Acomplia Concerns to Be Aired by FDA Advisory Panel in July
Few in France to Get Reimbursement for Diet Drug Acomplia
Diet Pill Acomplia Seen Becoming 'Gold Standard' for Treating Obesity
Diet Drug Acomplia Now on Sale in Some Mexican Border Pharmacies |
| |
Rimonabant News for February 2007-- News About Diet Drugs |
| |
Diet Drug Acomplia Seen Unlikely to Get FDA OK for 'Metabolic Syndrome'
Diet Pill Acomplia (Rimonabant) Hits New Three-Month Delay at U.S. FDA
Diet Drug Acomplia Gets French OK Limited to Obese Diabetics
Most Significant "Wait Loss" for Diet Drug Acomplia Is Loss of Sanofi Lead |
| |
Rimonabant News for January 2007 -- News About Diet Drugs |
| |
UK Company Plans Trial of Diet Drug With Same Target as Acomplia
Diet Pill Rimonabant (Acomplia / Zimulti) Not Yet Available in Mexico
Diet Drug Acomplia Rejected for Coverage by German Health Insurance
Expert Says Overactive Endocannibanoid System May Be Key to Obesity |
| |
Rimonabant News for Jan. to Dec. 2006 -- Click for 2006 News Achive |
| |
Rimonabant News for Jan. to Dec. 2005 -- Click for 2005 News Achive |
| |
Rimonabant News for Jan. to Dec. 2004 -- Click for 2004 News Achive |
We subscribe to the HONcode principles of the HON Foundation. 